Literature DB >> 26858136

Predictors of cardiac rehabilitation attendance following primary percutaneous coronary intervention for ST-elevation myocardial infarction in Australia.

Soon Yeng Soo Hoo1,2, Robyn Gallagher3, Doug Elliott2.   

Abstract

Cardiac rehabilitation is an important component of recovery and secondary prevention following urgent primary percutaneous coronary intervention. However, attendance and factors that predict participation by patients admitted with ST-elevation myocardial infarction remain unclear. This Australian study was conducted using a descriptive, comparative design. Consecutive patients (n = 246) at two hospitals were interviewed by telephone at four weeks and six months. Open-ended questions were used to assess cardiac rehabilitation attendance, sociodemographics, modifiable risk factors, clinical outcomes, and post-discharge health support. Post-discharge home visits at four weeks (odds ratio: 2.64, 95% confidence interval: 1.48-4.71) and at six months were associated with better cardiac rehabilitation attendance; more males participated at four weeks and at six months. The results suggest the need to integrate post-discharge health support with cardiac rehabilitation to facilitate recovery after primary percutaneous coronary intervention, particularly for females with ST-elevation myocardial infarction.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  ST-elevation; attendance; cardiac rehabilitation; gender; myocardial infarction; percutaneous coronary intervention

Mesh:

Year:  2016        PMID: 26858136     DOI: 10.1111/nhs.12258

Source DB:  PubMed          Journal:  Nurs Health Sci        ISSN: 1441-0745            Impact factor:   1.857


  7 in total

1.  A Motivational Telephone Intervention to Reduce Early Dropouts in Cardiac Rehabilitation: A FEASIBILITY PILOT STUDY.

Authors:  Grace LaValley; Andrew Storer; Heidi Szalai; Michel Farah; Quinn R Pack
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-09       Impact factor: 2.081

2.  Participant Exercise-Session Attendance in Community-Based, Bridging, and Hospital-Based Cardiac Rehabilitation: A Retrospective Case-Control Study.

Authors:  Stephanie K Nathanail; Gabor T Gyenes; Andrea Van Damme; Tara C Meyer; Eric C Parent; Michael D Kennedy
Journal:  CJC Open       Date:  2021-12-09

Review 3.  Mobile Phone Technologies in the Management of Ischemic Heart Disease, Heart Failure, and Hypertension: Systematic Review and Meta-Analysis.

Authors:  Praveen Indraratna; Daniel Tardo; Jennifer Yu; Kim Delbaere; Matthew Brodie; Nigel Lovell; Sze-Yuan Ooi
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-06       Impact factor: 4.773

4.  Effects of multidisciplinary exercise management on patients after percutaneous coronary intervention: A randomized controlled study.

Authors:  Ya-Jie Shi; Yu Liu; Tong-Tong Jiang; Hong-Ru Zhang; Tie-Ying Shi
Journal:  Int J Nurs Sci       Date:  2022-06-21

5.  Mobile Technology Use Across Age Groups in Patients Eligible for Cardiac Rehabilitation: Survey Study.

Authors:  Robyn Gallagher; Kellie Roach; Leonie Sadler; Helen Glinatsis; Julie Belshaw; Ann Kirkness; Ling Zhang; Patrick Gallagher; Glenn Paull; Yan Gao; Stephanie Ruth Partridge; Helen Parker; Lis Neubeck
Journal:  JMIR Mhealth Uhealth       Date:  2017-10-24       Impact factor: 4.773

6.  Mobile Technology Utilization Among Patients From Diverse Cultural and Linguistic Backgrounds Attending Cardiac Rehabilitation in Australia: Descriptive, Case-Matched Comparative Study.

Authors:  Ling Zhang; Ding Ding; Lis Neubeck; Patrick Gallagher; Glenn Paull; Yan Gao; Robyn Gallagher
Journal:  JMIR Cardio       Date:  2018-06-26

7.  Comparison of the pathways of care and life courses between first-time ST-elevation myocardial infarction (STEMI) and STEMI with prior MI: findings from the OSCAR registry.

Authors:  Laurie Fraticelli; Olivier Kleitz; Clément Claustre; Nicolas Eydoux; Alexandra Peiretti; Karim Tazarourte; Eric Bonnefoy-Cudraz; Claude Dussart; Carlos El Khoury
Journal:  BMJ Open       Date:  2020-11-05       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.